Bullboard - Stock Discussion Forum Delcath Systems Inc DCTH

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT) percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while... see more

Add To Watchlist

NDAQ:DCTH - Post Discussion

Delcath Systems Inc

View:

Comment by Iseneschal on Apr 30, 2021 9:25am

RE:Very interesting, life extending system.

ofnid wrote: Looking backwards this stock has been a disaster however their technology is being used in Europe to extend people's lives. Seems to have a very small market cap for what they have. Now that they have wiped out the former shareholders and recapitalized maybe it has a chance? Last financing was at $10.

Good call.......your timing was perfect.
I left more on the table than I made......who knew it would get to $25?

Taking another look at this......putting on watch for a repeat maybe.

Cheers !

152